Terms: = Colorectal cancer AND ATM, TELO1, 472, ENSG00000149311, TEL1, ATD, ATE, DKFZp781A0353, AT1, Q13315, MGC74674, ATDC, ATC, ATA
635 results:
1. Association of the Advanced Lung cancer Inflammation Index (ALI) and Gustave Roussy Immune (GRIm) score with immune checkpoint inhibitor efficacy in patients with gastrointestinal and lung cancer.
Jiang H; Li B; Wu M; Wang Q; Li Y
BMC Cancer; 2024 Apr; 24(1):428. PubMed ID: 38589844
[TBL] [Abstract] [Full Text] [Related]
2. Synergistic targeting of TrxR1 and atm/AKT pathway in human colon cancer cells.
Shen X; Xia Y; Lu H; Zheng P; Wang J; Chen Y; Xu C; Qiu C; Zhang Y; Xiao Z; Zou P; Cui R; Ni D
Biomed Pharmacother; 2024 May; 174():116507. PubMed ID: 38565059
[TBL] [Abstract] [Full Text] [Related]
3. The feasibility and acceptability of an app-based intervention with brief behavioural support (APPROACH) to promote brisk walking in people diagnosed with breast, prostate and colorectal cancer in the UK.
Lally P; Kennedy F; Smith S; Beeken RJ; Buck C; Thomas C; Counsell N; Wyld L; Martin C; Williams S; Roberts A; Greenfield DM; Gath J; Potts HWW; Latimer N; Smith L; Fisher A
Cancer Med; 2024 Mar; 13(6):e7124. PubMed ID: 38529687
[TBL] [Abstract] [Full Text] [Related]
4. Canonical DDR activation by EMT inducing agent 5-Fluorouracil is modulated by a cannabinoid based combinatorial approach via inducing autophagy and suppression of vimentin expression.
Mir KB; Chakraborty S; Amin T; Kumar A; Rouf War A; Nalli Y; Kumar R; Dinesh Kumar L; Ali A; Goswami A
Biochem Pharmacol; 2024 May; 223():116126. PubMed ID: 38490521
[TBL] [Abstract] [Full Text] [Related]
5. Examining cancer screening disparities by race/ethnicity and insurance groups: A comparison of 2008 and 2018 National Health Interview Survey (NHIS) data in the United States.
Sun J; Frick KD; Liang H; Chow CM; Aronowitz S; Shi L
PLoS One; 2024; 19(2):e0290105. PubMed ID: 38416784
[TBL] [Abstract] [Full Text] [Related]
6. Integrated bioinformatics approach to unwind key genes and pathways involved in colorectal cancer.
Mobeen SA; Saxena P; Jain AK; Deval R; Riazunnisa K; Pradhan D
J Cancer Res Ther; 2023 Oct; 19(7):1766-1774. PubMed ID: 38376276
[TBL] [Abstract] [Full Text] [Related]
7. Tumor acidosis-induced DNA damage response and tetraploidy enhance sensitivity to atm and ATR inhibitors.
Aubert L; Bastien E; Renoult O; Guilbaud C; Özkan K; Brusa D; Bouzin C; Richiardone E; Richard C; Boidot R; Léonard D; Corbet C; Feron O
EMBO Rep; 2024 Mar; 25(3):1469-1489. PubMed ID: 38366255
[TBL] [Abstract] [Full Text] [Related]
8. RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in colorectal cancer.
Singh H; Sahgal P; Kapner K; Corsello SM; Gupta H; Gujrathi R; Li YY; Cherniack AD; El Alam R; Kerfoot J; Andrews E; Lee A; Nambiar C; Hannigan AM; Remland J; Brais L; Leahy ME; Rubinson DA; Schlechter BL; Meyerson M; Kuang Y; Paweletz CP; Lee JK; Quintanilha JCF; Aguirre AJ; Perez KJ; Huffman BM; Rossi H; Abrams TA; Kabraji S; Trusolino L; Bertotti A; Sicinska ET; Parikh AR; Wolpin BM; Schrock AB; Giannakis M; Ng K; Meyerhardt JA; Hornick JL; Sethi NS; Cleary JM
Clin Cancer Res; 2024 Apr; 30(8):1669-1684. PubMed ID: 38345769
[TBL] [Abstract] [Full Text] [Related]
9. Discovery of the first ataxia telangiectasia and Rad3-related (ATR) degraders for cancer treatment.
Huang L; Shao J; Lai W; Gu H; Yang J; Shi S; Wufoyrwoth S; Song Z; Zou Y; Xu Y; Zhu Q
Eur J Med Chem; 2024 Mar; 267():116159. PubMed ID: 38325007
[TBL] [Abstract] [Full Text] [Related]
10. Alterations in the gut microbiota and their metabolites in human intestinal epithelial cells of patients with colorectal cancer.
Jahani-Sherafat S; Azimirad M; Raeisi H; Azizmohammad Looha M; Tavakkoli S; Ahmadi Amoli H; Moghim S; Rostami-Nejad M; Yadegar A; Zali MR
Mol Biol Rep; 2024 Feb; 51(1):265. PubMed ID: 38302841
[TBL] [Abstract] [Full Text] [Related]
11. Methylation of NRIP3 Is a Synthetic Lethal Marker for Combined PI3K and ATR/atm Inhibitors in colorectal cancer.
Zhang M; Li X; Herman JG; Gao A; Wang Q; Yao Y; Shen F; He K; Guo M
Clin Transl Gastroenterol; 2024 Mar; 15(3):e00682. PubMed ID: 38235705
[TBL] [Abstract] [Full Text] [Related]
12. Tolerance to colibactin correlates with homologous recombination proficiency and resistance to irinotecan in colorectal cancer cells.
Sogari A; Rovera E; Grasso G; Mariella E; Reilly NM; Lamba S; Mauri G; Durinikova E; Vitiello PP; Lorenzato A; Avolio M; Piumatti E; Bonoldi E; Aquilano MC; Arena S; Sartore-Bianchi A; Siena S; Trusolino L; Donalisio M; Russo M; Di Nicolantonio F; Lembo D; Bardelli A
Cell Rep Med; 2024 Feb; 5(2):101376. PubMed ID: 38228147
[TBL] [Abstract] [Full Text] [Related]
13. DNA polymerase ε and δ variants drive mutagenesis in polypurine tracts in human tumors.
Ostroverkhova D; Tyryshkin K; Beach AK; Moore EA; Masoudi-Sobhanzadeh Y; Barbari SR; Rogozin IB; Shaitan KV; Panchenko AR; Shcherbakova PV
Cell Rep; 2024 Jan; 43(1):113655. PubMed ID: 38219146
[TBL] [Abstract] [Full Text] [Related]
14. colorectal cancer Screening in the Elderly: Does Increased Prevalence Necessitate Tighter Surveillance.
Suki M; Abu-Baker F; Beshara A; Ovadia B; Gal O; Kopelman Y
Isr Med Assoc J; 2023 Dec; 25(12):815-818. PubMed ID: 38142321
[TBL] [Abstract] [Full Text] [Related]
15. Colonic stent as a bridge to surgery versus emergency rection for malignant left-sided colorectal obstruction: A systematic review and meta-analysis of randomized controlled trials.
Shang R; Han X; Zeng C; Lv F; Fang R; Tian X; Ding X
Medicine (Baltimore); 2023 Dec; 102(50):e36078. PubMed ID: 38115371
[TBL] [Abstract] [Full Text] [Related]
16. Risks of hypertension and thromboembolism in patients receiving bevacizumab with chemotherapy for colorectal cancer: A systematic review and meta-analysis.
Chitkara A; Kaur N; Desai A; Mehta D; Anamika F; Sarkar S; Gowda N; Sethi P; Thawani R; Chen EY
Cancer Med; 2023 Dec; 12(24):21579-21591. PubMed ID: 38069531
[TBL] [Abstract] [Full Text] [Related]
17. [The structure of pathogenic germline variants in colorectal cancer in Moscow patients].
Semenova AB; Byakhova MM; Makarova MV; Galkin VN; Nemtsova MV; Chernevskiy DK; Danishevich AM; Shatalov VG; Babkina AV; Popova NG; Gadzhieva SM
Arkh Patol; 2023; 85(6):16-25. PubMed ID: 38010635
[TBL] [Abstract] [Full Text] [Related]
18. Rate of Pathogenic Germline Variants in Patients With Lung cancer.
Sorscher S; LoPiccolo J; Heald B; Chen E; Bristow SL; Michalski ST; Nielsen SM; Lacoste A; Keyder E; Lee H; Nussbaum RL; Martins R; Esplin ED
JCO Precis Oncol; 2023 Sep; 7():e2300190. PubMed ID: 37992258
[TBL] [Abstract] [Full Text] [Related]
19. APC/PIK3CA mutations and β-catenin status predict tankyrase inhibitor sensitivity of patient-derived colorectal cancer cells.
Chen M; Mashima T; Oishi T; Muramatsu Y; Seto Y; Takamatsu M; Kawata N; Morino S; Nakamura A; Inaba S; Yuan X; Maruyama K; Suzuki M; Sato A; Yoshida H; Jang MK; Mizutani A; Takeuchi K; Yamaguchi K; Shirai F; Nagayama S; Katayama R; Seimiya H
Br J Cancer; 2024 Jan; 130(1):151-162. PubMed ID: 37968472
[TBL] [Abstract] [Full Text] [Related]
20. Determining Stable Structure and in Vitro Antiproliferative Properties of a Novel 3-(2-((4-Trifluoromethyl)phenyl)amino)thiazol-4-yl)-2H-chromen-2-one Molecule.
Burak Sarigüney A; Karakaş Sarikaya E; Pehlivanoğlu S
Chem Biodivers; 2024 Jan; 21(1):e202301216. PubMed ID: 37870095
[TBL] [Abstract] [Full Text] [Related]
[Next]